Company
Headquarters: Quincy, FL, United States
Employees: 6,900
CEO: Ms. Kimberly Rivers
$1.74 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, West Virginia, Arizona, and Maryland, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under Cultivar Collection, Momenta, Muse, Sweet Talk, Alchemy, Avenue, Co2lors, Loveli, Modern Flower, and Roll One brands. As of February 10, 2022, the company operated 161 dispensaries, including 112 dispensaries in Florida. Trulieve Cannabis Corp. has a strategic partnership with SLANG Worldwide Inc. to supply branded cannabis products in Massachusetts. The company is headquartered in Quincy, Florida.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Trulieve Cannabis Corp has the following listings and related stock indices.
Stock: OTC: TCNNF wb_incandescent
Stock: CSE: TRUL wb_incandescent
Stock: FSX: T0A wb_incandescent